County

Adams, Benton, Franklin, Yakima Counties

Current140 dose entries43 drugs1 documentWAeffective 2025-01-0196% machine-parsed of 140

Adams, Benton, Franklin, Yakima Counties (WA) carries 43 drugs across 140 dose entries in its current published protocol, effective 2025-01-01.

Drugs and doses43

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	650–1000 mg	PO	not captured	standing	pages 52, 118, 170
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	pages 52, 118, 170
Seizure	peds	20 mg/kg	PR	not captured	standing	pages 74, 170

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	6 mg	IV	not captured	standing	pages 45, 170
Other	peds	0.1 mg/kg	IV	not captured	standing	pages 45, 170

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 54, 79, 81, 82, 170, 177
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 54, 79, 81, 82, 170, 177

Albuterol-Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	3 mL	NEB	not captured	standing	pages 55, 79, 82, 177
Asthma / bronchospasm	adult	3 mL	NEB	not captured	standing	pages 55, 79, 82, 177
Asthma / bronchospasm	peds	Same as adult	NEB	not captured	standing	pages 55, 79, 82, 177
Asthma / bronchospasm	peds	Same as adult	NEB	not captured	standing	pages 55, 79, 82, 177

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	300 mg	IV/IO	not captured	standing	pages 43, 171
Cardiac arrest	peds	5 mg/kg	IV/IO	not captured	standing	pages 43, 171
Other	adult	150 mg	IV	not captured	standing	pages 45, 171
Other	peds	5 mg/kg	IV	not captured	standing	pages 45, 171

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 39, 171

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV	not captured	standing	pages 37, 172
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 37, 172
Organophosphate poisoning	peds	0.05 mg/kg	IV	not captured	standing	page 172

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1 g	IV	not captured	standing	page 73

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	1–2 g	IV	not captured	standing	pages 49, 173
Hyperkalemia	adult	1–2 g	IV	not captured	standing	pages 49, 173

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	pages 64, 65, 72
Hypoglycemia	peds	0.5–1 g/kg	IV/IO	not captured	standing	pages 64, 65, 72
Other	adult	25 g	IV	not captured	standing	page 76

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–5 mg	IV/IM	not captured	standing	pages 176, 185
Agitation	adult	2–5 mg	IV/IM	not captured	standing	pages 176, 185
Other	adult	2–10 mg	IV/IM	not captured	standing	pages 176, 185
Other	peds	0.1–0.3 mg/kg	IV/IM	not captured	standing	pages 176, 185
Procedural sedation	adult	2–10 mg	IV/IM	not captured	standing	pages 176, 185
Procedural sedation	peds	0.1–0.3 mg/kg	IV/IM	not captured	standing	pages 176, 185

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	0.25 mg/kg	IV	not captured	standing	pages 45, 176
SVT	adult	0.25 mg/kg	IV	not captured	standing	pages 45, 176

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	PO	not captured	standing	pages 54, 177
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 54, 177
Allergic reaction	peds	1–2 mg/kg	PO	not captured	standing	pages 54, 177
Allergic reaction	peds	1–2 mg/kg	IV/IO/IM	not captured	standing	pages 54, 177
Dystonic reaction	adult	25–50 mg	PO	not captured	standing	page 177
Dystonic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 177

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	2–10 mcg/kg	IV/IO	not captured	standing	page 177
Bradycardia	peds	Same as adult	IV/IO	not captured	standing	page 177

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IV/IM	not captured	standing	pages 57, 182

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	0.3–0.5 mg	IM	not captured	standing	pages 178, 179
Allergic reaction	peds	0.01 mg/kg	IM	not captured	standing	pages 178, 179
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 54, 55, 178, 179
Anaphylaxis	adult	0.3–0.5 mg	IV/IO	not captured	standing	pages 55, 178
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 54, 55, 178, 179
Asthma / bronchospasm	adult	0.3–0.5 mg	IM	not captured	standing	pages 79, 80, 82, 178, 179
Asthma / bronchospasm	adult	0.3–0.5 mg	IV	not captured	standing	pages 79, 178
Asthma / bronchospasm	peds	0.01 mg/kg	IM	not captured	standing	pages 79, 80, 82, 178, 179
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 37, 178, 179
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 37, 178, 179
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 43, 178, 179
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 43, 178, 179
Hypotension / shock	adult	5–20 mcg	IV	not captured	standing	pages 110, 178

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1–3 mcg/kg	IV	not captured	standing	pages 109, 180
Other	adult	1 mcg/kg	IV/IO	not captured	standing	page 180
Other	peds	1 mcg/kg	IV/IO	not captured	standing	page 180
Mild to moderate pain	adult	2 mcg/kg	IN	not captured	standing	page 118
Mild to moderate pain	adult	50 mcg	IV/IO/IM	not captured	standing	page 118
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM	not captured	standing	page 118

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV	not captured	standing	pages 72, 181, 182
Beta-blocker / calcium-channel-blocker overdose	adult	2 mg	IV	not captured	standing	pages 72, 181, 182
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg	IV	not captured	standing	pages 72, 181, 182
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg	IV	not captured	standing	pages 72, 181, 182
Hypoglycemia	adult	1 mg	IM	not captured	standing	pages 64, 181
Other	adult	2 mg	IV	not captured	standing	pages 38, 67, 72, 181

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mL	NEB	not captured	standing	pages 79, 81, 182
Asthma / bronchospasm	peds	2.5 mL	NEB	not captured	standing	pages 79, 81, 182

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	1–2 mg/kg	IV	not captured	standing	pages 57, 183
Agitation	adult	250 mg	IM	not captured	standing	pages 57, 183
Other	adult	1–2 mg/kg	IV	not captured	standing	pages 120, 183
Other	adult	250–500 mg	IM	not captured	standing	pages 120, 183
Other	peds	1 mg/kg	IV	not captured	standing	pages 120, 183
Mild to moderate pain	adult	15 mg	IV	not captured	standing	pages 118, 183
Procedural sedation	adult	1–2 mg/kg	IV	not captured	standing	pages 144, 183, 187
Procedural sedation	adult	250 mg	IM	not captured	standing	pages 144, 183
Procedural sedation	peds	0.5–1 mg/kg	IV	not captured	standing	pages 144, 183, 187
RSI induction	adult	1–2 mg/kg	IV	not captured	standing	pages 108, 183

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	pages 118, 184
Mild to moderate pain	adult	30 mg	IM	not captured	standing	pages 118, 184

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–0.75 mg/kg	IV/IO	not captured	standing	pages 171, 184
Other	adult	20–50 mg	IO	not captured	standing	pages 100, 101, 184
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 171, 184
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 171, 184

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1–2 mg	IV/IM/IN	not captured	standing	page 185
Agitation	adult	1–2 mg	IV/IM/IN	not captured	standing	page 185
Other	adult	0.5–1 mg	IV	not captured	standing	page 185
Other	adult	2–4 mg	IV/IM/IN	not captured	standing	pages 75, 185
Other	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 75, 185
Procedural sedation	adult	1–2 mg	IV/IM/IN	not captured	standing	pages 122, 185
Procedural sedation	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	pages 122, 185

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	2–4 g	IV	not captured	standing	pages 70, 185
Other	adult	2 g	IV	not captured	standing	page 186
Wide-complex tachycardia	adult	2 g	IV	not captured	standing	page 186
VF / pulseless VT	adult	2 g	IV	not captured	standing	page 186

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	125 mg	IV	not captured	standing	page 55
Asthma / bronchospasm	adult	125 mg	IV	not captured	standing	pages 79, 80, 82
Asthma / bronchospasm	peds	1–2 mg/kg	IV	not captured	standing	pages 79, 80, 82
COPD	adult	125 mg	IV	not captured	standing	pages 81, 191

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM	not captured	standing	pages 53, 186

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	peds	0.2 mg/kg	IV/IM/IN	not captured	standing	pages 57, 75, 186
Post-intubation sedation	adult	2.5–5 mg	IV/IM	not captured	standing	pages 109, 187
Procedural sedation	adult	1–5 mg	IV/IO	not captured	standing	page 122
RSI induction	adult	2.5–5 mg	IV/IM	not captured	standing	pages 108, 187
RSI induction	peds	0.5–1 mg	IV/IM	not captured	standing	pages 108, 187

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–4 mg	IV	not captured	standing	pages 40, 187
Mild to moderate pain	adult	2–10 mg	IV/IO/IM	not captured	standing	pages 118, 187
Mild to moderate pain	peds	0.1–0.2 mg/kg	IV/IO/IM	not captured	standing	pages 118, 187

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IN	not captured	standing	pages 71, 76, 188
Opioid overdose	adult	0.4–2 mg	IV/IO/IM	not captured	standing	pages 71, 76, 188

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4 mg	SL	not captured	standing	pages 39, 40
Other	adult	0.4 mg	SL	not captured	standing	page 41
Other	adult	2 inch	TOP	not captured	standing	page 41

Nitrous Oxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	Self-administered	NEB	not captured	standing	pages 52, 189
Mild to moderate pain	peds	Self-administered	NEB	not captured	standing	pages 52, 189

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	2–4 mcg	IV/IO	not captured	standing	page 38
Other	adult	2–4 mcg	IV/IO	not captured	standing	page 67
Sepsis	adult	2–4 mcg	IV/IO	not captured	standing	page 78
Sepsis	peds	0.1–2 mcg/kg	IV/IO	not captured	standing	page 78

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4–8 mg	PO	not captured	standing	pages 52, 68
Nausea / vomiting	adult	4–8 mg	IV/IO/IM	not captured	standing	pages 53, 68

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 64

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	20 mg	IV/IO	not captured	standing	page 190
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 190

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.25–0.5 mL	NEB	not captured	standing	pages 55, 79, 83, 190
Other	peds	0.25–0.5 mL	NEB	not captured	standing	pages 55, 79, 83, 190

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5 mg/kg	IV	not captured	standing	page 109
RSI paralysis	adult	1–1.5 mg/kg	IV	not captured	standing	page 109

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mEq/kg	IV	not captured	standing	pages 72, 191
Other	peds	1 mEq/kg	IV	not captured	standing	pages 72, 191
Tricyclic overdose	adult	1 mEq/kg	IV	not captured	standing	page 72

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 mg/kg	IV	not captured	standing	page 113
RSI paralysis	adult	1–2 mg/kg	IV	not captured	standing	pages 108, 192
RSI paralysis	peds	1–2 mg/kg	IV	not captured	standing	pages 108, 192

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV	not captured	standing	pages 72, 77, 192
Other	peds	25 mg	IV	not captured	standing	pages 72, 77, 192

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV	not captured	standing	pages 67, 89, 192, 193

Vasopressin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	40 unit	IV	not captured	standing	page 193

Ziprasidone

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	10–20 mg	IM	not captured	standing	pages 144, 180, 181

Cite this

Adams, Benton, Franklin, Yakima Counties, United States EMS Protocol Census. 140 dose entries, effective 2025-01-01.

https://protoquiz.com/census/agencies/adams-benton-franklin-yakima-counties/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.